<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01308788</url>
  </required_header>
  <id_info>
    <org_study_id>IGPS-prost-OAG</org_study_id>
    <nct_id>NCT01308788</nct_id>
  </id_info>
  <brief_title>Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow</brief_title>
  <official_title>Examination of the Effect of Aqueous Suppressant Versus Aqueous Outflow Enhancing Glaucoma Medications on Ocular Perfusion Pressure and Blood Flow: A Mechanistic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study will be to compare the aqueous production suppressant to aqueous
      outflow drugs in terms of the response to known vascular parameters. Specifically; systemic
      perfusion pressure, retrobulbar blood flow and retinal microcirculation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study will be to compare the aqueous production suppressant to aqueous
      outflow drugs in terms of the response to known vascular parameters. Specifically; systemic
      perfusion pressure, retrobulbar blood flow and retinal microcirculation.

      A comparison of perfusion pressure, retinal microcirculation utilizing Heidelberg Retinal
      Flowmetry and retrobulbar circulation utilizing color Doppler ultrasound imaging
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>6-month Change in Ophthalmic Artery (OA) Peak Systolic Velocity (PSV)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Phthalmic Artery (OA) End Diastolic Velocity (EDV)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Phthalmic Artery (OA) Vascular Resistance (RI)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Central Retinal Artery (CRA) Peak Systolic Velocity (PSV)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Central Retinal Artery (CRA) End Diastolic Velocity (EDV)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Central Retinal Artery (CRA) Vascular Resistance (RI)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6-month Change in Ocular Perfusion Pressures (OPP)</measure>
    <time_frame>Baseline and 6 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in OA PSV</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in OA EDV</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in OA RI</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in CRA PSV</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in CRA EDV</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in CRA RI</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-year Change in OPP</measure>
    <time_frame>Baseline and 24 month visits</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>aqueous suppressant</arm_group_label>
    <description>aqueous suppressant treated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aqueous outflow</arm_group_label>
    <description>aqueous outflow treated</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        120 glacuoma patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients will meet all of the following inclusion criteria to enter the study:

          1. Age: 30 years or older.

          2. Diagnosis: confirmed open-angle glaucoma in at least one eye:

               1. glaucomatous visual field loss on Humphrey 24-2 or 10-2 perimetry

               2. glaucomatous optic disc cupping

               3. agreement between two baseline exams for reliability

          3. Best corrected visual acuity at least 20/60 in at least one eye.

          4. Prior Humphrey visual fields demonstrate acceptable reliability standards (see below).

        Exclusion Criteria:

          1. Extensive Humphrey visual field damage consisting of either a mean deviation (MD) &lt;
             -15 decibels or a clinically determined threat to fixation in both hemifields.

          2. Evidence of exfoliation or pigment dispersion.

          3. History of acute angle-closure or a narrow, occludable anterior chamber angle by
             gonioscopy.

          4. History of chronic or recurrent inflammatory eye diseases (e.g., scleritis, uveitis).

          5. History or signs of intraocular trauma.

          6. Severe or potentially progressive retinal disease such as retinal degeneration,
             diabetic retinopathy, and retinal detachment.

          7. Any abnormality preventing reliable applanation tonometry.

          8. Current use of any ophthalmic or systemic steroid which may interfere with this
             investigation.

          9. Cataract surgery within the past year.

         10. Resting pulse &lt; 50 beats per minute.

         11. Severe, unstable or uncontrolled cardiovascular, renal, or pulmonary disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alon Harris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2011</study_first_submitted>
  <study_first_submitted_qc>March 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2011</study_first_posted>
  <results_first_submitted>September 20, 2013</results_first_submitted>
  <results_first_submitted_qc>January 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 27, 2014</results_first_posted>
  <last_update_submitted>January 23, 2014</last_update_submitted>
  <last_update_submitted_qc>January 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glaucoma blood flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>recited over 6 months</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Aqueous Outflow</title>
          <description>aqueous outflow treated</description>
        </group>
        <group group_id="P2">
          <title>Aqueous Suppressant</title>
          <description>aqueous suppressant treated</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>6-month Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>2-year Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>medication change by treating physician</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There will be (as shown) differences in the number of subjects based upon the time of analysis due to patient loss, data of insufficient quality at visit, or change in the drug use during period of study (patient switched off treatment by their doctor) so the number of data points varies throughout the analysis by availability.</population>
      <group_list>
        <group group_id="B1">
          <title>Aqueous Suppressant</title>
          <description>aqueous suppressant treated</description>
        </group>
        <group group_id="B2">
          <title>Aqueous Outflow</title>
          <description>aqueous outflow treated</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Ophthalmic Artery (OA) Peak Systolic Velocity (PSV)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Ophthalmic Artery (OA) Peak Systolic Velocity (PSV)</title>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.70" spread="2.57"/>
                    <measurement group_id="O2" value="1.84" spread=".96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.4414</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Phthalmic Artery (OA) End Diastolic Velocity (EDV)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Phthalmic Artery (OA) End Diastolic Velocity (EDV)</title>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.36" spread=".78"/>
                    <measurement group_id="O2" value=".12" spread=".44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.7820</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Phthalmic Artery (OA) Vascular Resistance (RI)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Phthalmic Artery (OA) Vascular Resistance (RI)</title>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".003" spread=".011"/>
                    <measurement group_id="O2" value=".014" spread=".013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.5496</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Central Retinal Artery (CRA) Peak Systolic Velocity (PSV)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Central Retinal Artery (CRA) Peak Systolic Velocity (PSV)</title>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.16" spread=".28"/>
                    <measurement group_id="O2" value=".09" spread=".25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.2930</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Central Retinal Artery (CRA) End Diastolic Velocity (EDV)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Central Retinal Artery (CRA) End Diastolic Velocity (EDV)</title>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.13" spread=".10"/>
                    <measurement group_id="O2" value="-.03" spread=".11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.5058</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Central Retinal Artery (CRA) Vascular Resistance (RI)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Central Retinal Artery (CRA) Vascular Resistance (RI)</title>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".029" spread=".018"/>
                    <measurement group_id="O2" value=".005" spread=".010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.6156</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-month Change in Ocular Perfusion Pressures (OPP)</title>
        <time_frame>Baseline and 6 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>6-month Change in Ocular Perfusion Pressures (OPP)</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.38" spread="2.26"/>
                    <measurement group_id="O2" value="-.63" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.5443</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in OA PSV</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in OA PSV</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.39" spread="3.05"/>
                    <measurement group_id="O2" value="2.63" spread="3.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.7847</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in OA EDV</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in OA EDV</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.28" spread=".71"/>
                    <measurement group_id="O2" value=".34" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.1331</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in OA RI</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in OA RI</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".035" spread=".016"/>
                    <measurement group_id="O2" value=".019" spread=".029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.5431</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in CRA PSV</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in CRA PSV</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.46" spread=".64"/>
                    <measurement group_id="O2" value=".19" spread=".50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.0684</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in CRA EDV</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in CRA EDV</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>cm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".43" spread=".24"/>
                    <measurement group_id="O2" value=".16" spread=".33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.2500</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in CRA RI</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <population>one participant was unable to be measured for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in CRA RI</title>
          <population>one participant was unable to be measured for this outcome</population>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".005" spread=".017"/>
                    <measurement group_id="O2" value="-.010" spread=".030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.6896</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-year Change in OPP</title>
        <time_frame>Baseline and 24 month visits</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aqueous Outflow</title>
            <description>aqueous outflow treated</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Suppressant</title>
            <description>aqueous suppressant treated</description>
          </group>
        </group_list>
        <measure>
          <title>2-year Change in OPP</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.26" spread="3.36"/>
                    <measurement group_id="O2" value="-3.02" spread="4.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.7965</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events were not assessed/collected as a part of this study protocol</desc>
      <group_list>
        <group group_id="E1">
          <title>Aqueous Outflow</title>
          <description>aqueous outflow treated</description>
        </group>
        <group group_id="E2">
          <title>Aqueous Suppressant</title>
          <description>aqueous suppressant treated</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small number of subjects at final endpoint, participation number various by analysis and date</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Alon Harris</name_or_title>
      <organization>Indiana University</organization>
      <phone>3170278-0177</phone>
      <email>alharris@indiana.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

